FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine, namely to remedies for hepatitis, and can be used for the treatment and prevention of liver diseases. Use of 6-hydroxy-2,2,4-trimethyl-1,2-dihydroquinoline of the general formula I.
as a hepatoprotective agent is proposed.
EFFECT: technical result consists in expanding the range of hepatoprotectors through a new, more active agent, which reduces the degree of development of oxidative stress in toxic hepatitis.
1 cl, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT POSSESSING HEPATOPROTECTIVE ACTION | 2020 |
|
RU2727931C1 |
| METHOD OF NONSPECIFIC RESISTANCE INCREASE OF BROILER CHICKEN | 2007 |
|
RU2370094C2 |
| AGENT POSSESSING ANTIARRHYTHMIC AND HEPATOPROTECTIVE PROPERTIES | 2011 |
|
RU2469720C1 |
| HEPATOPROTECTIVE AGENT POSSESSING ANTIOXIDANT ACTIVITY AND METHOD FOR ITS PREPARING | 2005 |
|
RU2310467C2 |
| HERBAL AGENT POSSESSING HEPATOPROTECTIVE ACTION | 2014 |
|
RU2554493C1 |
| METHOD FOR PRODUCTION OF SIBERIAN CEDAR SEEDS LIQUEUR AND HEPATOPROTECTIVE PREPARATION PRODUCED BY SUCH METHOD | 2014 |
|
RU2545700C1 |
| METHOD OF TREATING LIVER DISEASES OF VARIOUS GENESES | 2009 |
|
RU2400233C1 |
| HEPATOPROTECTIVE SUBSTANCE | 2015 |
|
RU2614691C2 |
| METHOD OF CORRECTION OF OXIDATIVE STATUS IN PARKINSON'S DISEASE IN EXPERIMENT | 2023 |
|
RU2800859C1 |
| USING DELTA SLEEP INDUCING PEPTIDE FOR HEPATOPROTECTIVE EFFECT IN CHRONIC IMMOBILISATION STRESS | 2013 |
|
RU2538686C1 |
